SME Times is powered by   
Search News
Just in:   • Global cues push equity markets higher, auto, IT stocks rise  • Nikki Haley praises India for 'not backing down' against China  • 'New definition to boost credit flow to MSMEs'  • Vedanta to be excluded from Nifty50 due to delisting  • Shah meets CMs of Delhi, Haryana, UP over unified Covid19 strategy 
Last updated: 29 Jun, 2020  

Tablet.9.Thmb.jpg Pharma sector seeks clearance of imported APIs, medical devices

Tablet.9.jpg
   Top Stories
» 'New definition to boost credit flow to MSMEs'
» Shah meets CMs of Delhi, Haryana, UP over unified Covid19 strategy
» Auto sales pick up in June
» Post COVID support required to electric vehicles: FICCI
» $750 mn World Bank loan for covid-hit MSMEs
SME Times News Bureau | 29 Jun, 2020
The strict customs scrutiny and non-clearance of imports from China has now hit the pharmaceutical sector -- the lifeline amid the pandemic -- making industry representatives to reach out to the government and seek urgent clearance of the goods at ports and airports.

In a communication to the Secretary, Department of Pharmaceuticals, the Pharmaceutical Export Promotion Council of India (Pharmexcil) said that it has been inundated with distress calls from its member companies over an acute disruption in manufacturing of pharmaceutical products over the last three days.

The letter was also marked to the Prime Minister's Office and the Directorate General of Foreign Trade among others.

"Very critical KSM's (Key Starting Material), intermediates & API's (Active Pharmaceutical Ingredients) are not being cleared for the reasons not known to the industry at all," said the letter by Dinesh Dua, Chairman, Pharmexcil.

Even critical devices such as 'infrared thermometers' and 'pulse oximeters' which are specifically aimed at covid diagnosis as also 'glucometers' and 'strips' are also held up at the Delhi airport, he said.

The letter dated June 27 noted that self reliance or the "Atamnirbharta" principle will take its own time in a phased and considered manner through the government's incentives such as 'pharma parks' as also 'production linked incentives' (PLI).

Describing the delay in customs clearances as "man-made" disruptions, the industry body said that they have created tremendous difficulties for the industry and if the clearances are not made on top priority "whatever great work" has been done to maintain the current 90-100 per cent production and supply chain may get completely diluted.

"We urgently appeal to you to kindly intervene in the matter on SOS and kindly instruct that clearances from customs are permitted and all these materials which are genuine in nature are allowed to be cleared and dispatched to ensure there is no disruption of manufacturing at all under any circumstances," it said.

Pharmexcil is just another industry body which has in the past few days reached out to the government and raised concerns over the delay in customs clearance and its impact on the supply chain.

Previously, the Apparel Export Promotion Council and India Cellular and Electronics Association reached out to the government last week seeking early customs clearance of their imported goods needed in the manufacturing process.

 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 03 Jul, 2020
  Daily Poll
COVID-19 has directly affected your business
 Yes
 No
 Can't say
  Commented Stories
» Starting an import export business: Basic guide for beginners(3)
» Govt. approves subsidy for 2,221 cold storages(1)
» Social entrepreneurship unique and full of challenges: Hasina Kharbhih(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter